YUNGJIN PHARM. CO., LTD Logo

YUNGJIN PHARM. CO., LTD

003520 | KO

Overview

Corporate Details

ISIN(s):
KR7003520004
LEI:
Country:
South Korea
Address:
서울특별시 송파구 올림픽로35다길 13 국민연금 잠실사옥 2~3층, 송파구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-28 00:00
Regulatory Filings
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 6.1 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.2 MB
2025-08-14 00:00
Quarterly Report
[기재정정]분기보고서 (2025.03)
Korean 695.0 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 879.7 KB
2025-08-13 00:00
Environmental & Social Information
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean 11.1 KB
2025-08-01 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 13.3 KB
2025-07-31 00:00
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결
Korean 12.9 KB
2025-07-25 00:00
Share Issue/Capital Change
[기재정정]신규시설투자등
Korean 13.7 KB
2025-05-30 00:00
Major Shareholding Notification
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Korean 90.6 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 681.6 KB
2025-05-07 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 13.3 KB
2025-03-28 00:00
AGM Information
정기주주총회결과
Korean 33.7 KB
2025-03-28 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.7 KB
2025-03-20 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.2 MB
2025-03-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 492.1 KB

Automate Your Workflow. Get a real-time feed of all YUNGJIN PHARM. CO., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for YUNGJIN PHARM. CO., LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for YUNGJIN PHARM. CO., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Lineage Cell Therapeutics Inc. Logo
Developing off-the-shelf cell therapies for neurological and ophthalmic conditions.
Israel
LCTX
Lipidor AB Logo
Develops topical skin treatments by reformulating drugs with a lipid-based delivery platform.
Sweden
LIPI
Lipocine Inc. Logo
Biopharma developing oral drugs for metabolic & endocrine disorders using delivery technology.
United States of America
LPCN
Liquidia Corp Logo
Develops inhaled therapies for rare cardiopulmonary diseases using proprietary PRINT® technology.
United States of America
LQDA
LISATA THERAPEUTICS, INC. Logo
Oncology firm with a platform for more effective, targeted delivery of anti-cancer drugs.
United States of America
LSTA
Longeveron Inc. Logo
Develops cell therapies for Alzheimer's, aging frailty, and rare infant heart defects.
United States of America
LGVN
Lonza Group AG Logo
A leading CDMO for pharma, biotech & nutrition, providing end-to-end development & manufacturing.
Switzerland
LONN
Lyell Immunopharma, Inc. Logo
Develops durable CAR T-cell therapies for solid tumors & blood cancers by reprogramming T-cells.
United States of America
LYEL
Lyra Therapeutics, Inc. Logo
Developing localized, long-acting therapies for chronic rhinosinusitis (CRS).
United States of America
LYRA
Lytix Biopharma AS Logo
Develops oncolytic peptide immunotherapies that kill cancer and stimulate an anti-tumor response.
Norway
LYTIX

Talk to a Data Expert

Have a question? We'll get back to you promptly.